RNA modifications, including structural alterations in RNA‐binding proteins like Fused in Sarcoma (FUS), m6A modification, and A‐to‐I RNA editing, have been linked to the pathophysiology of ALS. Here, FUS is linked to amyotrophic lateral sclerosis.